Galectin Therapeutics Inc (NASDAQ:GALT)

Data as of Jan 30
 -0.23 / -6.67%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 4
Quarter 1
Quarter 2
Quarter 3
Revenue and IncomeNet Revenues0.
Depreciation And Amortization3.0K2.0K3.0K3.0K
Operating ExpensesGross Income-3.0K-2.0K-3.0K-3.0K
General Expenses2.8M4.8M3.4M3.5M
Research And Development1.4M2.8M1.6M2.0M
Total Operating Expenses2.8M4.8M3.4M3.5M
Non-Operating ExpensesOperating Income-2.8M-4.8M-3.4M-3.5M
Pre-Tax Equity Earnings---270.0K-67.0K-53.0K
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.8M-5.1M-3.4M-3.5M
Preferred Dividend-254.0K-240.0K-302.0K-278.0K
Net Income-2.9M-5.2M-3.4M-3.6M
Shares To Calculate EPSShares To Calculate EPS20.7M20.3M22.0M22.1M
Shares To Calculate EPS Diluted20.7M20.3M22.0M22.1M
Earnings Per ShareEPS-$0.15-$0.27-$0.17-$0.17
EPS Diluted-$0.15-$0.27-$0.17-$0.17

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.